corporate overview


Cardiovascular diseases and complications are one of the leading causes of death worldwide, and prevalence is still increasing mainly due to modern lifestyles. Most cardiovascular complications stem from the presence of one or more risk factors, notably hypertension, obesity, type 2 diabetes, NASH/fibrosis, dyslipidemia…

Cardiomedex is a preclinical CRO, highly specialized in cardiovascular diseases and complications, which provides reliable preclinical studies using integrative models. Since our creation in 2011, we have been helping pharmaceutical and biotechnology companies involved in large drug development programs to tackle these issues and improve patients’ quality of life.

Cardiomedex works with dozens of international clients to assess the cardiac efficacy and safety of compounds intended for human use. We offer expert preclinical CRO services with cutting-edge technology, allowing us to provide our clients with tailor-made solutions as well as reliable results that are quality compliant.

Our mission and services
Cardiomedex has joined forces with pharmaceutical companies to improve health and change patients’ lives for the better. We offer innovative and integrated models that mimic the human situation and combine co-morbidities/risk factors such as diabetes, hyperlipidemia, obesity and NASH. Our highly skilled and flexible team provides value-added expertise to maximize your research potential and streamline drug development, repositioning and lifecycle extension management.

Preclinical drug development and Post launched studiesConsulting

Our values
  • We listen: our approach is fully focused on our clients’ project needs in order to design the best solution for them.
  • We excel: we are chosen by our clients for our scientific excellence.
  • We control: our high-quality standards allow us to deliver highly reliable results.
  • We provide: a flexible and quick response to our clients’ demands.
Research Tax Credits Accredited CRO

To support our innovative R&D projects, Cardiomedex has been accredited with Research Tax Credits by the French Ministry of Higher Education and Research.
All expenses for R&D or innovative projects are eligible for Research Tax Credits.